Chongqing Sansheng Industrial Co.,Ltd. Share Price

Equities

002742

CNE100001WZ4

Construction Materials

End-of-day quote Shenzhen S.E. 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
2.34 CNY +4.93% Intraday chart for Chongqing Sansheng Industrial Co.,Ltd. +0.86% -30.77%

Financials

Sales 2022 2.08B 287M 23.01B Sales 2023 2.03B 280M 22.49B Capitalization 1.46B 202M 16.17B
Net income 2022 -318M -43.93M -3.52B Net income 2023 -452M -62.43M -5.01B EV / Sales 2022 1.69 x
Net Debt 2022 1.55B 215M 17.21B Net Debt 2023 984M 136M 10.9B EV / Sales 2023 1.2 x
P/E ratio 2022
-6.17 x
P/E ratio 2023
-3.22 x
Employees 2,245
Yield 2022 *
-
Yield 2023
-
Free-Float 60.8%
More Fundamentals * Assessed data
Dynamic Chart
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
An unknown buyer acquired a 8.55% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen and Pan Chenggong CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chongqing Sansheng Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
Chongqing Quanliuxin Building Materials Co., Ltd. cancelled the acquisition of Chongqing Hechuan District Sansheng Building Materials Co., Ltd. from Chongqing Sansheng Industrial Co.,Ltd.. CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chongqing Sansheng Industrial Co.,Ltd. Announces Board Appointments CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chongqing Sansheng's Shareholder Plans to Cut 3% Stake CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chongqing Quanliuxin Building Materials Co., Ltd. signed an agreement to acquire Chongqing Hechuan District Sansheng Building Materials Co., Ltd. from Chongqing Sansheng Industrial Co.,Ltd. for CNY 86.7 million. CI
Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day+4.93%
1 week+0.86%
Current month-23.03%
1 month-23.03%
3 months-31.38%
6 months-33.14%
Current year-30.77%
More quotes
1 week
2.07
Extreme 2.07
2.34
1 month
2.07
Extreme 2.07
3.10
Current year
2.07
Extreme 2.07
3.78
1 year
2.07
Extreme 2.07
4.19
3 years
2.07
Extreme 2.07
7.83
5 years
2.07
Extreme 2.07
8.65
10 years
2.07
Extreme 2.07
31.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 28/02/10
Director of Finance/CFO 50 31/10/19
Chief Tech/Sci/R&D Officer 47 31/01/17
Members of the board TitleAgeSince
Director/Board Member 52 31/05/16
Director/Board Member 72 -
Chief Executive Officer 57 28/02/10
More insiders
Date Price Change Volume
30/04/24 2.34 +4.93% 1,351,250
29/04/24 2.23 +5.19% 11,408,950
26/04/24 2.12 -3.64% 14,166,950
25/04/24 2.2 -5.17% 11,472,700
24/04/24 2.32 +4.98% 14,060,800

End-of-day quote Shenzhen S.E., April 29, 2024

More quotes
Chongqing Sansheng Industrial Co.,Ltd., formerly Chongqing Sansheng Industrial Co., Ltd.,is a China-based company principally engaged in the comprehensive utilization and product development of plaster resources and pharmaceutical business. The Company operates through two main segments. The Construction Materials and Chemical Industry segment is mainly involved in the manufacturing and sales of commercial concretes, water reducing agents, expanding agents and sulfuric acids. The Company’s products are mainly applied in the construction, tunnels, bridges, seaports, roads, chemical fertilizers, chemical engineering, light manufacturing, textiles, steels and others. The Pharmaceutical Business segment is primarily involved in the production, research and development of raw material medicines, preparation products and intermediate products.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002742 Stock